Adelaide researchers have been honoured for their leading international role in discoveries that have delivered life-changing benefits for people with chronic myeloid leukaemia (CML).
As recently as a few decades ago, CML brought with it an average life expectancy of just five years. Thanks to researchers like those led by Professor Tim Hughes at SAHMRI, the disease is now manageable for most people, and prognoses continue to improve.
Professor Hughes was joined by colleagues from SAHMRI, the Royal Adelaide Hospital, SA Pathology and the University of South Australia last week to receive the 2023 Hall of Fame Award from the Australasian Leukaemia & Lymphoma Group (ALLG).
The group commended SA-based CML researchers “in recognition of your global impact (in making) a number of outstanding contributions to the advancement of research into blood cancers and played a pivotal role in many of the ALLG’s clinical trials”.
